Recombinant vaccinia (human papillomavirus) April 12, 2017 Recombinant vaccinia (human papillomavirus) Trade Name Ta-Hpv Orphan Indication Cervical cancer USA Market Approval USA USA Designation Date 1994-08-24 00:00:00 Sponsor Xenova Research Limited;310 Cambridge Science Park, Cambridge CB4 OWG;